You’ve probably heard of Ozempic—the diabetes drug that has become a fave of celebs and border-hopping Americans for its weight loss capabilities—because it’s literally everywhere. 

Driving the news: From sports to social media, advertisements for pharma giant Novo Nordisk’s smash hit are inescapable, which has left some medical professionals worried about a wave of overprescriptions, leading to shortages and an uptick in nasty side effects.

Cancer rates among people aged 25 to 29 have increased faster than any other age group over the past three decades, a new analysis by the Financial Times showed.

Catch up: In the G20 group of industrialized countries, cancer rates for people between the ages of 20 and 34 are higher than they’ve been in three decades. 

Today in news that you will not find shocking, a drink called Hype Sauce may not be a totally healthy beverage choice.

You may know ketamine by its use as an animal sedative or status as a Schedule 1 drug, but the demand for it as a treatment for anxiety and depression is also booming. 

Driving the news: Canada is currently facing a shortage of the powerful drug, a result of sustained demand combined with a shortage of a variety of ingredients needed to make it. 

It will soon be easier than ever for Ontarians to find a doctor with a charming accent.

Canada’s chief science advisor released a report on long Covid, claiming the illness could trigger a “mass-disabling event” with the potential to ravage healthcare and labour markets. 

Healthcare. It’s the word on every premiers’ lips. And yesterday, they finally got to talk to the Prime Minister about it.

Do you believe in magic? What about magic mushrooms?

You may soon be able to get a lot more than a massage and 75% off your next physio appointment with your workplace health insurance.

Amid a flurry of recent announcements, it’s clear that efforts to help a healthcare industry in crisis are kicking into high gear.